Share

Cramer vets biotech giants Biogen, Celgene, Gilead and Regeneron for positive prospects

Jim Cramer examines "the four horsemen of biotech" to see if their weakening stocks can regain momentum.
07:40
Thu, May 10 20186:51 PM EDT